Cryosite (ASX:CTE) Asset Impairment Charge : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Cryosite Asset Impairment Charge?

Cryosite's Asset Impairment Charge for the six months ended in Dec. 2024 was A$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Cryosite Asset Impairment Charge Historical Data

The historical data trend for Cryosite's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Asset Impairment Charge Chart

Cryosite Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Asset Impairment Charge

Get a 7-Day Free Trial

Cryosite Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Cryosite Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Cryosite Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Cryosite's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryosite Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142

Website

https://www.cryosite.com

Cryosite Ltd is engaged in the provision of supply chain logistics, and management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. The clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labeling, status management, secondary packaging, scheduled drug distribution, destruction, returns, and biological services.

Cryosite Headlines

No Headlines